Total Funding
2
Total FundingSeries B raised
Growth Score in past quarter
pts
Heat Score 2 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3728807
Aires Pharmaceuticals is a clinical stage pharmaceutical company developing therapies to treat pulmonary disorders.
Julie Crawford: Sr. Director of Finance and AdministrationPast Role: Cabrellis Pharmaceuticals, Team Member
About the Company
Aires Pharmaceuticals, Inc., a clinical stage pharmaceutical company, develops therapies to treat pulmonary disorders. The company offers Aironite, an inhaled drug that is used to treat adult and pediatric pulmonary hypertension, cystic fibrosis, pneumonia, and other respiratory infections. It also develops products for the treatment of bacterial
pulmonary infections. Aires Pharmaceuticals was founded in 2006 and is based in San Diego, California.


